pyrroles has been researched along with Alveolar Soft Part Sarcoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, T; Luo, Z; Wang, C; Wang, H; Wang, L; Zhang, S; Zhang, X | 1 |
| Falkowski, S; Jagodzińska-Mucha, P; Klimczak, A; Koseła-Paterczyk, H; Kozak, K; Rogala, P; Rutkowski, P; Świtaj, T; Wągrodzki, M; Ługowska, I | 1 |
| Brich, S; Casali, PG; Crippa, F; Gronchi, A; Marrari, A; Morosi, C; Orsenigo, M; Pierotti, MA; Pilotti, S; Rota, SA; Stacchiotti, S; Tamborini, E | 1 |
| Benesch, M; Hanzer, M; Nebl, A; Pilhatsch, A; Spendel, S; Urban, C | 1 |
| Ghose, A; Tariq, Z; Veltri, S | 1 |
| Bozzi, F; Brich, S; Casali, PG; Cassinelli, G; Conca, E; Gronchi, A; Morosi, C; Negri, T; Palassini, E; Pilotti, S; Stacchiotti, S; Zaffaroni, N | 1 |
| Brisse, H; Coulomb, A; Helfre, S; Hilbert, M; Larroquet, M; Mary, P; Orbach, D; Serinet, MO | 1 |
7 other study(ies) available for pyrroles and Alveolar Soft Part Sarcoma
| Article | Year |
|---|---|
A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; China; Female; Follow-Up Studies; Humans; Indoles; Lung Neoplasms; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Prognosis; Pyrroles; Retrospective Studies; Sarcoma, Alveolar Soft Part; Sunitinib; Survival Rate; Young Adult | 2016 |
Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma.
Topics: Adult; Aged; Bone Neoplasms; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Hand-Foot Syndrome; Humans; Indoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrroles; Sarcoma, Alveolar Soft Part; Sunitinib | 2017 |
Response to sunitinib malate in advanced alveolar soft part sarcoma.
Topics: Adult; Drug Evaluation; ErbB Receptors; Female; Humans; Indoles; Male; Middle Aged; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-akt; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Sarcoma, Alveolar Soft Part; Signal Transduction; Sunitinib; TOR Serine-Threonine Kinases | 2009 |
Necrosis of a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Compassionate Use Trials; Female; Follow-Up Studies; Humans; Indoles; Lung Neoplasms; Necrosis; Postoperative Complications; Pyrroles; Radiotherapy, Adjuvant; Reoperation; Sarcoma, Alveolar Soft Part; Skin Transplantation; Soft Tissue Neoplasms; Sunitinib; Surgical Flaps; Thigh | 2010 |
Treatment of multidrug resistant advanced alveolar soft part sarcoma with sunitinib.
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Bone Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Indoles; Lung Neoplasms; Male; Pyrroles; Quality of Life; Sarcoma, Alveolar Soft Part; Sunitinib; Treatment Outcome | 2012 |
Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect.
Topics: Adult; Antineoplastic Agents; Blotting, Western; Cell Proliferation; Female; Flow Cytometry; Fluorescent Antibody Technique; Follow-Up Studies; Humans; Immunoenzyme Techniques; Immunoprecipitation; In Situ Hybridization, Fluorescence; Indoles; Male; Middle Aged; Proto-Oncogene Proteins c-ret; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Retrospective Studies; Sarcoma, Alveolar Soft Part; Sunitinib; Survival Rate; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2; Young Adult | 2011 |
Alveolar soft part sarcoma in childhood: is Sunitinib-Sutent® treatment an effective approach?
Topics: Adolescent; Angiogenesis Inhibitors; Child; Combined Modality Therapy; Female; Humans; Indoles; Lung Neoplasms; Pyrroles; Receptor Protein-Tyrosine Kinases; Sarcoma, Alveolar Soft Part; Sunitinib | 2012 |